Johnson & Johnson : JNJ

All Johnson & Johnson Articles

1191 Articles

Douglas A. McIntyre | Nov 1, 2007 at 12:30 PM EDT

Defensive Stocks Show No Panic Rotation (PEP, KO, BUD, TAP, KFT, CAG, CPB, HRL, MCD, MO, VGR, RAI, PG, CL, MRK, JNJ, NVO)

With the markets down so much today on the financial stock fallout after the Citi downgrade/concern and with oil stocks…

Douglas A. McIntyre | Oct 21, 2007 at 10:17 AM EDT

For Boston Scientific And JNJ, The Stent Stats Get Worse

"William O’Neill, dean of clinical affairs at University of Miami’sMiller School of Medicine, says stent-patient traffic is beginning topick up…

Douglas A. McIntyre | Oct 16, 2007 at 9:07 AM EDT

Interpreting Amgen Sales From J&J’s PROCRIT (AMGN, JNJ)

Shares of Amgen Inc. (NASDAQ:AMGN) are under bit of pressure this morning, although not from any direct news from the…

Douglas A. McIntyre | Oct 16, 2007 at 7:03 AM EDT

Johnson & Johnson’s (JNJ) Good Quarter

Johnson & Johnson (JNJ) announced third-quarter sales of $15.0 billion, an increase of 12.7% as compared to the third quarter…

Douglas A. McIntyre | Oct 11, 2007 at 5:57 AM EDT

As Stent Business Falls Apart, Field Gets More Crowded

Medtronic (MDT) got the FDA to approve its new drug-coated stent called the Endeavor. The agency did have some concerns…

Douglas A. McIntyre | Oct 6, 2007 at 3:10 PM EDT

Medtronic (MDT): The Stent Business Gets Worse

Medtronic (MDT) has decided to get into the stent business, making the little mesh tubes that keep arteries open. It…

Douglas A. McIntyre | Oct 4, 2007 at 5:37 AM EDT

For Boston Scientific (BSX) Stent News Gets More Complex

Stent sales for Boston Scientific (BSX) and Johnson & Johnson (JNJ) have taken a big drop since research began to…

Douglas A. McIntyre | Sep 14, 2007 at 3:22 AM EDT

Media Digest 9/14/2007 Reuters, WSJ, NYTimes, FT, Barron’s

According to Reuters, Intel (INTC) received antitrust charges from a branch of the South Korean government. Reuters writes that Campbell…

Douglas A. McIntyre | Sep 13, 2007 at 7:32 AM EDT

ISIS Scores On J&J Collaboration & Milestones (ISIS, JNJ)

ISIS Pharmaceuticals Inc. (NASDAQ:ISIS) is trading up pre-market on new that it entered a broad collaboration with Ortho-McNeil, a Johnson…

Douglas A. McIntyre | Sep 12, 2007 at 7:25 AM EDT

Amgen Set To Run (AMGN, JNJ, BIIB)

Amgen Inc. (NASDAQ:AMGN) is seeing shares trade up another 2% pre-market after yesterday’s decision where an FDA panel rejected a…

Douglas A. McIntyre | Sep 7, 2007 at 3:32 PM EDT

Defensive Stock Picks Better Than The Market (September 7, 2007)

We are frequently asked about how certain basket picks perform compared to the overall market. It has been years since…

Douglas A. McIntyre | Sep 7, 2007 at 9:46 AM EDT

“Time To Go Defensive, Again?” (PEP, KO, BUD, TAP, KFT, CAG, CPB, HRL, MCD, MO, VGR, RAI, PG, CL, MRK, JNJ, NVO)

If you ever heard the old saying "Be careful what you wish for, you may get it!" it sure seems…

Douglas A. McIntyre | Sep 6, 2007 at 3:14 AM EDT

Media Digest 9/6/2007 Reuters, WSJ, NYTimes, FT, Barron’s

According to Reuters, Countrywide (CFC) will eliminate 900 jobs. Reuters writes that Apple (AAPL) is looking for higher sales and…

Douglas A. McIntyre | Sep 4, 2007 at 6:59 PM EDT

Boston Scientific (BSX): The Stent Business Can’t Get More Confused

After reports last week that drug-coated stents posed little risk to heart patients, a new survey shows that "patients given…

Douglas A. McIntyre | Sep 4, 2007 at 6:53 AM EDT

While You Were On Holiday…Here’s What You Missed

Last week was a light volume trading week, but the markets were open and they didn’t wait for the holiday…

1 … 76 77 78 79 80

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

Defensive Stocks Show No Panic Rotation (PEP, KO, BUD, TAP, KFT, CAG, CPB, HRL, MCD, MO, VGR, RAI, PG, CL, MRK, JNJ, NVO)

For Boston Scientific And JNJ, The Stent Stats Get Worse

Interpreting Amgen Sales From J&J’s PROCRIT (AMGN, JNJ)

Johnson & Johnson’s (JNJ) Good Quarter

As Stent Business Falls Apart, Field Gets More Crowded

Medtronic (MDT): The Stent Business Gets Worse

For Boston Scientific (BSX) Stent News Gets More Complex

Media Digest 9/14/2007 Reuters, WSJ, NYTimes, FT, Barron’s

ISIS Scores On J&J Collaboration & Milestones (ISIS, JNJ)

Amgen Set To Run (AMGN, JNJ, BIIB)

Defensive Stock Picks Better Than The Market (September 7, 2007)

“Time To Go Defensive, Again?” (PEP, KO, BUD, TAP, KFT, CAG, CPB, HRL, MCD, MO, VGR, RAI, PG, CL, MRK, JNJ, NVO)

Media Digest 9/6/2007 Reuters, WSJ, NYTimes, FT, Barron’s

Boston Scientific (BSX): The Stent Business Can’t Get More Confused

While You Were On Holiday…Here’s What You Missed

How Much Do You Really Need Invested to Replace a $60,000 Salary With Monthly Dividend ETFs?

Could You Retire On Florida’s Space Coast And Watch Rocket Launches From Your Backyard?

Oracle vs. Salesforce: Which Tech Giant Is The Better Buy?

How Much Do You Really Need Invested to Replace a $60,000 Salary With Monthly Dividend ETFs?

Could You Retire On Florida's Space Coast And Watch Rocket Launches From Your Backyard?

How Much Do You Really Need Invested to Replace a $60,000 Salary With Monthly Dividend ETFs?

Could You Retire On Florida’s Space Coast And Watch Rocket Launches From Your Backyard?

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

Defensive Stocks Show No Panic Rotation (PEP, KO, BUD, TAP, KFT, CAG, CPB, HRL, MCD, MO, VGR, RAI, PG, CL, MRK, JNJ, NVO)

For Boston Scientific And JNJ, The Stent Stats Get Worse

Interpreting Amgen Sales From J&J’s PROCRIT (AMGN, JNJ)

Johnson & Johnson’s (JNJ) Good Quarter

As Stent Business Falls Apart, Field Gets More Crowded

Medtronic (MDT): The Stent Business Gets Worse

For Boston Scientific (BSX) Stent News Gets More Complex

Media Digest 9/14/2007 Reuters, WSJ, NYTimes, FT, Barron’s

ISIS Scores On J&J Collaboration & Milestones (ISIS, JNJ)

Amgen Set To Run (AMGN, JNJ, BIIB)

Defensive Stock Picks Better Than The Market (September 7, 2007)

“Time To Go Defensive, Again?” (PEP, KO, BUD, TAP, KFT, CAG, CPB, HRL, MCD, MO, VGR, RAI, PG, CL, MRK, JNJ, NVO)

Media Digest 9/6/2007 Reuters, WSJ, NYTimes, FT, Barron’s

Boston Scientific (BSX): The Stent Business Can’t Get More Confused

While You Were On Holiday…Here’s What You Missed

How Much Do You Really Need Invested to Replace a $60,000 Salary With Monthly Dividend ETFs?

Could You Retire On Florida’s Space Coast And Watch Rocket Launches From Your Backyard?

Oracle vs. Salesforce: Which Tech Giant Is The Better Buy?

Featured Reads

How Much Do You Really Need Invested to Replace a $60,000 Salary With Monthly Dividend ETFs?

Could You Retire On Florida's Space Coast And Watch Rocket Launches From Your Backyard?